AllCare has received a growth investment from Summit Partners

AllCare Family Medicine & Urgent Care (AllCare) has received a growth investment from Summit Partners.

AllCare is a provider of tech-enabled primary care medical services in retail-based settings.

Summit Partners is a private equity firm based in Boston, Massachusetts. The firm focuses on investing in technology, healthcare, life sciences and other growth industries.

Oaklins’ team in Los Angeles acted as the exclusive advisor to seller in this transaction.

Services

M&A sell-side

Parteien

Sprechen Sie mit dem Deal-Team

Adam Abramowitz

Geschäftsführer

Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Profil ansehen Kontaktaufnahme

Kyle Berkman

Associate Director

Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Profil ansehen Kontaktaufnahme

Gavin Cutrino

Associate

Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Profil ansehen Kontaktaufnahme

Relevante Transaktionen

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Private Equity | Dienstleistungen | Bau- und Ingenieurdienstleistungen

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Weitere Informationen

Valmiermuižas Alus has been acquired by Cēsu Alus

Private Equity | Lebensmittel- und Getränkeindustrie

Valmiermuižas Alus has been acquired by Cēsu Alus

Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.

Weitere Informationen

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

Gesundheitswesen

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Weitere Informationen